Cite
HARVARD Citation
Chorzalska, A. et al. (2018). Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK‐ERK and NF‐κB pathways in a model of chronic myeloid leukemia. Molecular oncology. 12 (5), pp. 630-647. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chorzalska, A. et al. (2018). Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK‐ERK and NF‐κB pathways in a model of chronic myeloid leukemia. Molecular oncology. 12 (5), pp. 630-647. [Online].